BioXcel Therapeutics Inc.

NASDAQ: BTAI · Real-Time Price · USD
5.47
0.72 (15.16%)
At close: Aug 15, 2025, 3:59 PM
6.07
10.98%
After-hours: Aug 15, 2025, 07:58 PM EDT

BioXcel Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-59.6M -179.05M -165.76M -106.93M
Depreciation & Amortization
309K 318K 327K 297K
Stock-Based Compensation
6.16M 18.61M 17.34M 19.45M
Other Working Capital
-2.95M 5.07M -123K 130K
Other Non-Cash Items
-12.86M 3.1M 2.08M 46K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-6.03M 2.02M 10.67M 4.98M
Operating Cash Flow
-72.03M -155.01M -135.34M -82.15M
Capital Expenditures
n/a -20K -139K -445K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a -20K -139K -445K
Debt Repayment
-2.5M n/a 98.6M n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-528K -207K -2.65M 1.45M
Financial Cash Flow
36.66M 26.52M 96.24M 102.45M
Net Cash Flow
-35.37M -128.5M -39.24M 19.85M
Free Cash Flow
-72.03M -155.03M -135.48M -82.6M